ARDX
USDArdelyx Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$5.700
Kõrge
$5.780
Madal
$5.630
Maht
2.70M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.4B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
3.69M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10
Piper Sandler analyst Christopher Raymond maintains Ardelyx with a Neutral and raises the price target from $9 to $10.
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet
Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11
Citigroup analyst Yigal Nochomovitz maintains Ardelyx with a Buy and raises the price target from $10 to $11.
TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10
TD Cowen analyst Joseph Thome maintains Ardelyx with a Buy and raises the price target from $9 to $10.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.